Cell Therapeutics (CTIC) Posts Narrower Q1 Loss of 9c/Share

Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q1 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)